Skip to main content

Inhibikase Therapeutics, Inc 10-K for FY2024

Inhibikase Therapeutics, Inc. (IKT)

10-K 2025-03-27 For: 2024-12-31
View Original
Added on April 07, 2026

About this 10-K

Inhibikase Therapeutics, Inc filed this 10-K on March 27, 2025, covering the fiscal year ended December 31, 2024 (FY2024).

Headline figures

Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$0
compared with $260.5K a year earlier
Net loss
$27.52M
compared with a net loss of $19.03M a year earlier
Diluted EPS
-$1.16
compared with -$3.16 a year earlier